Olshan Frome Wolosky LLP advised Anebulo Pharmaceuticals on the deal.Anebulo Pharmaceuticals, Inc. executed its $21 million initial public offering and listing on The Nasdaq Capital Market under…
Anebulo Pharmaceuticals’ $21 Million Initial Public Offering
